Brinsupri, which Insmed acquired from AstraZeneca nearly a decade ago, is the first treatment for bronchiectasis that’s not ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

President Donald Trump said his administration would “deploy every tool” to get drug prices reduced from large pharmaceutical ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments. The data AstraZeneca released will be ...

Drugmakers AstraZeneca (AZN) and Daiichi Sankyo’s (DSKYF) cancer drug, Enhertu, has been added to China’s National Reimbursement Drug List (NRDL) and will be covered by state-run medical ...

AstraZeneca plc AZN is set to report its third-quarter 2024 earnings Tuesday morning, and the company's second-quarter performance hints at robust growth fueled by its oncology and cardiovascular ...

AstraZeneca's <AZN.L> sales fell by a bigger-than-expected 13 percent in the first quarter as patent expiries took a heavy toll, underscoring the turnaround challenge facing Britain's second ...